|
|
|
|
Vol. 56, Issue 3, 545-551, September 1999
Division of Nephrology, Department of Pharmacology and Vanderbilt
Cancer Center, Vanderbilt University School of Medicine, Nashville,
Tennessee
The ligand binding pocket of biogenic amine G protein-coupled receptors
is embedded in the membrane-spanning regions of these receptors,
whereas the extracellular domains of the peptidergic receptors play a
key role in the structure and function of this class of receptors. To
examine the role of the extracellular sequences in prostaglandin
receptor-ligand interaction, chimeras were constructed with the two
Gs-coupled E-prostanoid (EP) receptors, replacing each of the extracellular sequences of the human EP2
receptor with the corresponding human EP4 receptor
residues. Replacement of the third extracellular loop (ECIII) yielded a
receptor that binds [3H]prostaglandin E2
(PGE2; Kd = 6.3 nM) with
similar affinity as the EP2 wild-type receptor
(Kd = 12.9 nM). Similarly, replacement of the nonconserved carboxyl-terminal portion of ECII resulted in a
receptor that maintains [3H]PGE2 binding
(Kd = 8.8 nM). In contrast, replacement
of the amino terminus, ECI, the entire ECII region, or the residues
within the highly conserved motif of the amino-terminal half of ECII yielded chimeras that displayed neither detectable
[3H]PGE2 binding nor receptor-evoked cAMP
generation. Immunoprecipitation demonstrated that each chimera is
expressed at levels near that of wild-type receptors; however,
enzyme-linked immunosorbent assay revealed that inactive chimeras have
reduced cell surface expression. Similarly, chimeras that exchange the
multiple extracellular loop sequences N/ECI, ECII/ECIII, or all four
sequences lacked detectable binding and signal transduction, and
although expressed, were not detected on the cell surface. These data
suggest that the extracellular sequences of the EP2
receptor are critical determinants of receptor structure and/or
function, unlike other G protein-coupled receptors that bind small molecules.
This article has been cited by other articles:
![]() |
R. Li, K. P. Mouillesseaux, D. Montoya, D. Cruz, N. Gharavi, M. Dun, L. Koroniak, and J. A. Berliner Identification of Prostaglandin E2 Receptor Subtype 2 As a Receptor Activated by OxPAPC Circ. Res., March 17, 2006; 98(5): 642 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Konger, G. A. Scott, Y. Landt, J. H. Ladenson, and A. P. Pentland Loss of the EP2 Prostaglandin E2 Receptor in Immortalized Human Keratinocytes Results in Increased Invasiveness and Decreased Paxillin Expression Am. J. Pathol., December 1, 2002; 161(6): 2065 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Akal-Strader, S. Khare, D. Xu, F. Naider, and J. M. Becker Residues in the First Extracellular Loop of a G Protein-coupled Receptor Play a Role in Signal Transduction J. Biol. Chem., August 16, 2002; 277(34): 30581 - 30590. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Baillie, S. J. MacKenzie, and M. D. Houslay Phorbol 12-myristate 13-acetate Triggers the Protein Kinase A-Mediated Phosphorylation and Activation of the PDE4D5 cAMP Phosphodiesterase in Human Aortic Smooth Muscle Cells through a Route Involving Extracellular Signal Regulated Kinase (ERK) Mol. Pharmacol., November 1, 2001; 60(5): 1100 - 1111. [Abstract] [Full Text] |
||||
![]() |
M. D. Breyer and R. M. Breyer Prostaglandin E receptors and the kidney Am J Physiol Renal Physiol, July 1, 2000; 279(1): F12 - F23. [Abstract] [Full Text] [PDF] |
||||